The American Diabetes Association has released an update to its standards on the pharmacologic treatment of adults with type 2 diabetes. On the basis of new evidence, early combination therapy is now ...
Hanmi Pharmaceutical announced on June 10 that it will participate in the American Diabetes Association (ADA 2025) and present its innovative research achievements in the field of obesity treatments.
Terns Pharmaceuticals announced significant updates regarding TERN-601, a novel oral GLP-1R agonist, following a successful Phase 1 clinical study and the completion of enrollment in its Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback